These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34291090)

  • 1. Targeting the Host Response: Can We Manipulate Extracellular Matrix Metalloproteinase Activity to Improve Influenza Virus Infection Outcomes?
    Pedrina J; Stambas J
    Front Mol Biosci; 2021; 8():703456. PubMed ID: 34291090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.
    Sihler KC; Park PK
    Surg Infect (Larchmt); 2011 Apr; 12(2):151-8. PubMed ID: 21545282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Virus: A Master Tactician in Innate Immune Evasion and Novel Therapeutic Interventions.
    Hsu AC
    Front Immunol; 2018; 9():743. PubMed ID: 29755452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.
    Brazee PL; Sznajder JI
    Arch Bronconeumol (Engl Ed); 2020 Sep; 56(9):586-591. PubMed ID: 32405132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of influenza virus infection.
    Kandel R; Hartshorn KL
    BioDrugs; 2001; 15(5):303-23. PubMed ID: 11437694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
    Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.
    Jazayeri SD; Poh CL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31683888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
    Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.
    Cox RJ; Brokstad KA; Ogra P
    Scand J Immunol; 2004 Jan; 59(1):1-15. PubMed ID: 14723616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections.
    Francis ME; King ML; Kelvin AA
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30704019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor.
    Xia C; Wolf JJ; Sun C; Xu M; Studstill CJ; Chen J; Ngo H; Zhu H; Hahm B
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
    Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
    mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Extracellular Vesicles in Influenza Virus Infection.
    Jiang Y; Cai X; Yao J; Guo H; Yin L; Leung W; Xu C
    Front Cell Infect Microbiol; 2020; 10():366. PubMed ID: 32850473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering humoral immunity as prophylaxis or therapy.
    Deal CE; Balazs AB
    Curr Opin Immunol; 2015 Aug; 35():113-22. PubMed ID: 26183209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.